Federal Register: Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization, Draft Guidance for Industry and Food and Drug Administration Staff; Availability

The FDA is announcing the availability of the draft guidance entitled "Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization." This draft guidance addresses the inclusion of a boxed warning and a patient decision...

https://www.gpo.gov/fdsys/pkg/FR-2016-03-04/html/2016-04790.htm

Source: Food and Drug Adminstration (FDA): CDRHNew - March 4, 2016 Category: Medical Equipment Source Type: news

More News: Food and Drug Administration (FDA) | Hysteroscopy | Medical Devices | Tubal Ligation | Warnings